Managing Director at Ehrlich Group
Gal Ehrlich is the founder and managing director of the Ehrlich Group, a firm that specialises in the IP field. Dr Ehrlich has a BSc degree in biology and a PhD degree in genetic engineering received from the Hebrew University of Jerusalem. Gal also has an LLB degree received from the Tel Aviv University Law School.
Since 1994, Dr Ehrlich has been involved in preparing and prosecuting patent applications in all high-technology fields, including biotechnology, agro technology, medicine, pharmaceuticals, computers, communications, physics, chemistry, medical devices and more.
In 2000 Dr Ehrlich founded Ehrlich & Partners. In 2006 the firm merged with Fenster & Co to become Ehrlich & Fenster, which soon after become Israel’s leading patent attorneys firm. In 2017 Dr Ehrlich formed the Ehrlich Group, which includes, in addition to Ehrlich & Fenster, an IP boutique law firm (Ehrlich, Neubauer & Melzer, attorneys at law) and IP monetisation firm (IPTrade Ltd). The group employs around 150 individuals and serves thousands of clients, including Israel’s leading universities and academic institutions and many well-known international companies, start-ups and private clients.
The Ehrlich Group has been recognised as a leading patent attorney firm in Israel and has been ranked as a Tier 1 firm for many consecutive years by Managing Intellectual Property’s World IP Survey and IAM Patent 1000. The group is ranked Tier 1 for both patent prosecution and trademark and copyright prosecution in the Legal 500 2020. Dr Ehrlich himself has also been ranked individually as a Tier 1 professional by all IP major ranking entities.